Clinical Trial Update: Interferon Gamma-1b Administered Topically for Macular Edema/Intraretinal Schisis Cysts in Rod-Cone Dystrophy (RCD) and Enhanced S-Cone Syndrome (ESCS) [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial evaluating topically administered Interferon Gamma-1b for macular edema and intraretinal schisis cysts in rod-cone dystrophy and enhanced S-co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Enhanced S-cone Syndrome
• Rod-cone Dystrophy

Drugs mentioned

• Interferon-gamma 1b (interferon gamma-1b)

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Inherited Ophthalmic Diseases, Inherited Retinal Degeneration | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2019-08-06